The global market for Miscellaneous Antimalarials was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Misecellaneous antimalarials are drugs effective in the treatment of malaria. Malaria is an infectious disease caused by the bite of an anopheles mosquito infected with certain protozoans. Th...
The global market for IL-6 Inhibitors was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
IL-6 Inhibitors, which are now considered as promising treatment for COVID-19, target the IL-6 receptors (IL-6Rs), thereby preventing the binding of IL-6 ligands to IL-6 receptors. Thus, inhibiting the en...
The global market for High-Content Analysis (HCA) System was valued at US$ 660 million in the year 2024 and is projected to reach a revised size of US$ 974 million by 2031, growing at a CAGR of 5.8% during the forecast period.
HCA, AKA high-content screening systems (HCS), address a range of research applications from basic science to drug discovery screening. The device is usually paired with ana...
The global market for Humanized Antibody was valued at US$ 241 million in the year 2024 and is projected to reach a revised size of US$ 407 million by 2031, growing at a CAGR of 7.9% during the forecast period.
Humanized antibodies mainly refer to antibodies re-expressed by gene cloning and DNA recombination technology of mouse monoclonal antibodies, most of the amino acid sequences of which are r...
The global market for Teriflunomide was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Teriflunomide is an active metabolite of Leflunomide. It inhibits the synthesis of pyrimidine by inhibiting the enzyme dihydroorotate dehydrogenase, as an immunomodulator.
North American market for Teriflun...
The global market for Monoamine Oxidase Inhibitor (MAOIs) was valued at US$ 197 million in the year 2024 and is projected to reach a revised size of US$ 318 million by 2031, growing at a CAGR of 7.2% during the forecast period.
MAOIs are a class of drugs that inhibit the activity of one or both monoamine oxidase enzymes: monoamine oxidase A (MAO-A) and monoamine oxidase B (MAO-B). They are widely...
The global market for EGFR-TKI for Advanced NSCLC was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
EGFR tyrosine kinase inhibitors (TKIs) are molecules that could inhibt EGFR function through binding. Its monotherapy as first-line treatment can benefit NSCLC patients harbouring EGFR mutatio...
The global market for mRNA Therapy was valued at US$ 44900 million in the year 2024 and is projected to reach a revised size of US$ 105710 million by 2031, growing at a CAGR of 13.2% during the forecast period.
By delivering mRNA into a cell, the cell could be induced to produce any protein encoded by the mRNA. The protein produced can be used for medical prevention or treatment. The translatabili...
The global market for Gene Engineered Subunit Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
A gene engineered subunit vaccine or a bio-recombinant subunit vaccine refers to the expression of a protective antigen gene in a prokaryotic or eukaryotic cell, and a vaccine made from a...
The global market for Reversible Inhibitors of Monoamine (RIMA) Antidepressants was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
RIMAs are used as antidepressants. They work by reducing the activity of monoamine oxidase which is a chemical found throughout the body. Monoamine oxidase breaks...
Our team would be happy to assist you with your queries.
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals